These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20946917)

  • 1. Susceptibility to experimental autoimmune encephalomyelitis is associated with altered B-cell subsets distribution and decreased serum BAFF levels.
    Lee-Chang C; Lefranc D; Salleron J; Faveeuw C; Allet C; Vermersch P; Oxombre B; Prin L
    Immunol Lett; 2011 Mar; 135(1-2):108-17. PubMed ID: 20946917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.
    Huntington ND; Tomioka R; Clavarino C; Chow AM; Liñares D; Maña P; Rossjohn J; Cachero TG; Qian F; Kalled SL; Bernard CC; Reid HH
    Int Immunol; 2006 Oct; 18(10):1473-85. PubMed ID: 16914508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice.
    Dittel BN; Urbania TH; Janeway CA
    J Autoimmun; 2000 Jun; 14(4):311-8. PubMed ID: 10882057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses.
    Sanna V; Di Giacomo A; La Cava A; Lechler RI; Fontana S; Zappacosta S; Matarese G
    J Clin Invest; 2003 Jan; 111(2):241-50. PubMed ID: 12531880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from multiple sclerosis: models, concepts, observations.
    Wekerle H
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively.
    Constantinescu CS; Hilliard B; Ventura E; Wysocka M; Showe L; Lavi E; Fujioka T; Scott P; Trinchieri G; Rostami A
    Clin Immunol; 2001 Jan; 98(1):23-30. PubMed ID: 11141323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells.
    Yang M; Sun L; Wang S; Ko KH; Xu H; Zheng BJ; Cao X; Lu L
    J Immunol; 2010 Apr; 184(7):3321-5. PubMed ID: 20208006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
    J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
    Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
    Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inoculation of BCL1 lymphoma cells into CSJL/J F1 mice inhibits acute experimental autoimmune encephalomyelitis.
    Abramsky O; Karussis DM; Mizrachi-Koll R; Lehmann D
    Isr J Med Sci; 1994 Jan; 30(1):1-6. PubMed ID: 7511133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L
    Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell activating factor (BAFF) selects IL-10
    Ma N; Zhang Y; Liu Q; Wang Z; Liu X; Zhu G; Yu D; Han G; Chen G; Hou C; Wang T; Ma Y; Shen B; Li Y; Xiao H; Wang R
    Mol Immunol; 2017 May; 85():18-26. PubMed ID: 28199852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced costimulation by CD70+ B cells aggravates experimental autoimmune encephalomyelitis in autoimmune mice.
    Francosalinas G; Cantaert T; Nolte MA; Tak PP; van Lier RA; Baeten DL
    J Neuroimmunol; 2013 Feb; 255(1-2):8-17. PubMed ID: 23137837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct.
    Butterfield RJ; Blankenhorn EP; Roper RJ; Zachary JF; Doerge RW; Sudweeks J; Rose J; Teuscher C
    J Immunol; 1999 Mar; 162(5):3096-102. PubMed ID: 10072563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis.
    Ben-Nun A; Yossefi S; Lehmann D
    Eur J Immunol; 1993 Mar; 23(3):689-96. PubMed ID: 8095458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S; Morva A; Youinou P; Jamin C
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.